Valuation
Medical DevicesLive · Yahoo FinancePrice
$9.69
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
SWOT Analysis — OFIX
Inflationary BoomStrengths
EPS (Diluted): $-2.33 (+29.4% YoY) — Negative EPS — the company recorded a loss on a per-share basis.
Operating Cash Flow: $33.3M (+29.3% YoY) — Operating cash flow grew 29% — the business generated more cash from day-to-day operations.
Net Income: -$92.2M (+26.8% YoY) — The company posted a net loss — total expenses exceeded total revenue.
Weaknesses
Total Assets: $850.6M (-4.8% YoY) — Total assets shrank 5% — the balance sheet contracted.
Opportunities
Gross Profit: $566.0M (+3.7% YoY) — Gross profit rose 4% — the spread between revenue and direct costs improved.
Threats
Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability.
Stock is within 10% of its 52-week low (9.13) — the market may be pricing in significant risk or sector weakness.
Financial Charts
Revenue vs Net Income
Gross Profit vs Operating Income
Margin Trend
Operating Cash Flow
Year-over-Year Changes
EPS (Diluted)
$-2.33
was $-3.30
Negative EPS — the company recorded a loss on a per-share basis.
Operating Cash Flow
$33.3M
was $25.8M
Operating cash flow grew 29% — the business generated more cash from day-to-day operations.
Net Income
-$92.2M
was -$126.0M
The company posted a net loss — total expenses exceeded total revenue.
Total Assets
$850.6M
was $893.3M
Total assets shrank 5% — the balance sheet contracted.
Gross Profit
$566.0M
was $545.9M
Gross profit rose 4% — the spread between revenue and direct costs improved.
Risk Flags
1 high · 1 medium · 0 low- ⚠ High
Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability.
- ◈ Medium
Stock is within 10% of its 52-week low (9.13) — the market may be pricing in significant risk or sector weakness.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade OFIX
Links open broker research pages. Not an endorsement or recommendation.
Research ORTHOFIX MEDICAL INC.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.